| GUCA2B | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | GUCA2B, GCAP-II, UGN, guanylate cyclase activator 2B | ||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 601271 MGI: 1270851 HomoloGene: 5150 GeneCards: GUCA2B | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Guanylate cyclase activator 2B is a protein that in humans is encoded by the GUCA2B gene. [5]
Function
This gene encodes a preproprotein that is proteolytically processed to generate multiple protein products, including uroguanylin, a member of the guanylin family of peptides and an endogenous ligand of the guanylate cyclase-C receptor. Binding of this peptide to its cognate receptor stimulates an increase in cyclic GMP and may regulate salt and water homeostasis in the intestine and kidneys.
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000044012 - Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000032978 - Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Entrez Gene: Guanylate cyclase activator 2B". Retrieved 2017-07-04.
Further reading
- Sindić A, Hirsch JR, Velic A, Piechota H, Schlatter E (2005). "Guanylin and uroguanylin regulate electrolyte transport in isolated human cortical collecting ducts". Kidney Int. 67 (4): 1420–7. doi:10.1111/j.1523-1755.2005.00219.x. PMID 15780094.
- Guo HF, Gao PJ, Li Y, Zhu DL, Wang JG (2007). "[Association between uroguanylin G-247A polymorphism and blood pressure/fluid and electrolytes homeostasis]". Zhonghua Xin Xue Guan Bing Za Zhi (in Chinese). 35 (3): 233–6. PMID 17582287.
- Yoshikawa Y, Nakayama T, Saito K, Hui P, Morita A, Sato N, Takahashi T, Tamura M, Sato I, Aoi N, Doba N, Hinohara S, Soma M, Usami R (2007). "Haplotype-based case-control study of the association between the guanylate cyclase activator 2B (GUCA2B, Uroguanylin) gene and essential hypertension". Hypertens. Res. 30 (9): 789–96. doi:10.1291/hypres.30.789. PMID 18037771.
- Yoshikawa Y, Nakayama T, Saito K, Hui P, Morita A, Sato N, Takahashi T, Tamura M, Sato I, Aoi N, Doba N, Hinohara S, Soma M, Usami R (2007). "Haplotype-based case-control study of the association between the guanylate cyclase activator 2B (GUCA2B, Uroguanylin) gene and essential hypertension". Hypertens. Res. 30 (9): 789–96. doi:10.1291/hypres.30.789. PMID 18037771.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.